CD4 and breast cancer: Regarding the expression of γH2AX, a DNA damage response-related phosphorylated histone, we determined that DP CD4+ cells from BC patients exhibited the higher frequency of cells expressing this protein in comparison to the DN T subset from BC patients (Figure 2E) as well as the DP subset from HDs (Figure 2F).